Breaking News Instant updates and real-time market news.

AVEO

Aveo Pharmaceuticals

$0.95

-0.08 (-7.77%)

14:56
04/04/19
04/04
14:56
04/04/19
14:56

Piper maintains Overweight rating, $3 target on Aveo after stock sale

Piper Jaffray analyst Edward Tenthoff maintains his Overweight rating and $3 price target on Aveo Pharmaceuticals after the company "opportunistically" raised $25M by issuing 21.7M shares at $1.15 per share and 21.7M in warrants with a $1.25 strike price. The analyst, who estimates that Aveo now holds pro forma cash of about $57M, said the primary driver for the stock remains the OS analysis for TIVO-3 that is scheduled to be reported in Q4. If the hazard ratio does not drop to less than 1.0 for tivozanib, Tenthoff does not believe the FDA will accept a new NDA filing, he noted.

  • 04

    Apr

AVEO Aveo Pharmaceuticals
$0.95

-0.08 (-7.77%)

02/04/19
02/04/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Aveo Pharmaceuticals (AVEO) downgraded to Neutral from Buy at B. Riley FBR with analyst Harshita Polishetty saying she sees a financing overhang after the FDA recommended against the filing of the company's tivozanib new drug application. 2. BHP Billiton (BHP) downgraded to Underweight from Neutral at JPMorgan while Rio Tinto (RIO) was downgraded to Neutral from Overweight at. 3. SAP (SAP) downgraded to Neutral from Buy at BofA/Merrill. 4. MacroGenics (MGNX) downgraded to Sell from Neutral at Citi with analyst Yigal Nochomovitz saying his re-examination of the prior Phase 1 data underpinning the ongoing Phase 3 SOPHIA trial has led him to revise his base case expectation to a failure for the trial. 5. Okta (OKTA) downgraded to Sector Weight from Overweight at KeyBanc with analyst Rob Owens saying that while the Street clearly anticipates meaningful upside to expectations, he believes many of the upside scenarios render shares fairly valued at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/19/19
PIPR
02/19/19
NO CHANGE
Target $3
PIPR
Overweight
Aveo Pharmaceuticals should be bought on any weakness, says Piper Jaffray
Aveo Pharmaceuticals' full Phase III Tivo-3 data for tivozanib in an oral presentation on Saturday "showed clear advantage" for progression-free survival, overall response rate and safety, but the "immature" overall survival data show a hazard ratio of 1.12, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. The analyst believes that with more patients still on tivozanib, the hazard ratio could slip below 1.0 and meet the FDA filing requirement. He recommends buying shares of Aveo on weakness and keeps an Overweight rating on the name with a $3 price target.
03/15/19
03/15/19
NO CHANGE

Baird reiterates Outperform rating on Aveo after Q4 earnings
Baird analyst Madhu Kumar reiterated an Outperform rating and $2 price target on Aveo Pharmaceuticals after the company reported its Q4 earnings report. The analyst said in a research note partially titled "Clinical Basis for TIVO-3 OS Optimism" that he continues to have relative optimism to the Street for Fotivda, and added that a Q4 of 2019 update on TIVO-3 OS was a key potential positive catalyst for the stock.
03/28/19
NATL
03/28/19
INITIATION
NATL
Sell
Aveo Pharma initiated with a Sell, $0 price target at National Securities
National Securities initiated Aveo Pharmaceuticals with a Sell and $0 price target saying recent share appreciation is "totally unwarranted." The firm's analyst expects interim and final Phase 3 overall survival data updates to fail to support a Tivozanib NDA filing.

TODAY'S FREE FLY STORIES

FB

Facebook

$181.54

3.26 (1.83%)

16:06
04/22/19
04/22
16:06
04/22/19
16:06
Hot Stocks
Facebook names State Department's Jennifer Newstead as General Counsel »

Facebook announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

FB

Facebook

$181.57

3.29 (1.85%)

16:04
04/22/19
04/22
16:04
04/22/19
16:04
Hot Stocks
Facebook names State Department's Jennifer Newstead as General Counsel »

Facebook announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

ROKU

Roku

$58.20

1.51 (2.66%)

16:04
04/22/19
04/22
16:04
04/22/19
16:04
Initiation
Roku initiated at Susquehanna »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 22

    May

TCFC

Community Financial

$28.96

0.06 (0.21%)

16:03
04/22/19
04/22
16:03
04/22/19
16:03
Earnings
Community Financial reports Q1 EPS 70c, consensus 64c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$76.64

-1.07 (-1.38%)

15:55
04/22/19
04/22
15:55
04/22/19
15:55
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 09

    Jul

RTRX

Retrophin

$19.99

-0.08 (-0.40%)

15:51
04/22/19
04/22
15:51
04/22/19
15:51
Conference/Events
Retrophin management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 04

    May

  • 08

    May

  • 05

    Jun

  • 30

    Jun

BDRBF

Bombardier

$0.00

(0.00%)

15:43
04/22/19
04/22
15:43
04/22/19
15:43
Periodicals
Bombardier sees higher sales from modernizing existing rail cars, Reuters says »

Bombardier expects higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

DHI

D.R. Horton

$45.61

-0.815 (-1.76%)

15:40
04/22/19
04/22
15:40
04/22/19
15:40
Options
DR Horton draws call sellers after an analyst downgrade, ahead of earnings »

DR Horton draws call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NBL

Noble Energy

$27.78

0.66 (2.43%)

15:38
04/22/19
04/22
15:38
04/22/19
15:38
Hot Stocks
Noble Energy raises quarterly dividend 9% to 12c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 03

    May

RMBS

Rambus

$11.82

-0.08 (-0.67%)

15:34
04/22/19
04/22
15:34
04/22/19
15:34
Options
Rambus options imply 9.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 25

    Apr

  • 15

    May

  • 16

    May

TSLA

Tesla

$263.63

-9.62 (-3.52%)

, SSNLF

Samsung

$0.00

(0.00%)

15:24
04/22/19
04/22
15:24
04/22/19
15:24
Hot Stocks
Tesla confirms neural processor design custom by Tesla »

During Tesla's…

TSLA

Tesla

$263.63

-9.62 (-3.52%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

SBUX

Starbucks

$75.23

-0.84 (-1.10%)

15:24
04/22/19
04/22
15:24
04/22/19
15:24
Hot Stocks
Chinese Starbucks competitor Luckin Coffee files for U.S. listing »

According to the filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WHR

Whirlpool

$139.79

0.75 (0.54%)

15:19
04/22/19
04/22
15:19
04/22/19
15:19
Options
Whirlpool options imply 10.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

TSLA

Tesla

$263.10

-10.15 (-3.71%)

, NVDA

Nvidia

$188.97

2.71 (1.46%)

15:17
04/22/19
04/22
15:17
04/22/19
15:17
Hot Stocks
Tesla able to make more specific solution than Nvidia, CEO Musk says »

Comparing to Nvidia…

TSLA

Tesla

$263.10

-10.15 (-3.71%)

NVDA

Nvidia

$188.97

2.71 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

  • 22

    May

  • 10

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
04/22/19
04/22
15:17
04/22/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
04/22/19
04/22
15:16
04/22/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$263.15

-10.1 (-3.70%)

15:07
04/22/19
04/22
15:07
04/22/19
15:07
Hot Stocks
All Tesla cars being produced have all necessary for full self-driving »

Says people will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

WILC

G. Willi-Food

$8.30

(0.00%)

15:04
04/22/19
04/22
15:04
04/22/19
15:04
Hot Stocks
G. Willi-Food signs memorandums of understanding for potential acquisitions »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZION

Zions Bancorp

$46.77

-0.54 (-1.14%)

15:04
04/22/19
04/22
15:04
04/22/19
15:04
Options
Zions Bancorp options imply 4.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

CGC

Canopy Growth

$47.98

3.55 (7.99%)

15:00
04/22/19
04/22
15:00
04/22/19
15:00
Options
Buyers gobble up Canopy Growth calls as shares light up »

Buyers gobble up Canopy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$264.00

-9.25 (-3.39%)

14:59
04/22/19
04/22
14:59
04/22/19
14:59
Hot Stocks
Tesla highlights security of FSD computer »

Says if software is not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

TSLA

Tesla

$263.58

-9.67 (-3.54%)

14:54
04/22/19
04/22
14:54
04/22/19
14:54
Hot Stocks
'Any part could fail,' car will keep driving, Tesla CEO says »

Tesla CEO highlights…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

TSLA

Tesla

$263.56

-9.69 (-3.55%)

14:52
04/22/19
04/22
14:52
04/22/19
14:52
Hot Stocks
Tesla presents full self-driving tech, provides look at self-driving computer »

Pete Bannon, system…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

QEP

QEP Resources

$8.06

0.03 (0.37%)

14:50
04/22/19
04/22
14:50
04/22/19
14:50
Options
Bullish option play in QEP Resources ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

RRC

Range Resources

$9.75

-0.01 (-0.10%)

14:49
04/22/19
04/22
14:49
04/22/19
14:49
Options
Range Resources options imply 9.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 15

    May

  • 22

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.